ALLR

NASDAQ 已收盘

Allarity Therapeutics

0.79 USD
▼-0.08-9.25%
盘后 0.80 +1.91%
2026-11-20
市值
$12.49M
市盈率
—
EPS
-0.99
股息率
—
52 周区间
0.77 – 1.84
成交量
306.39K
Beta
0.57
目标价
—
52W 低 0.7752W 高 1.84
价格走势

公司简介

Allarity Therapeutics, Inc., a clinical-stage precision medicine pharmaceutical company, focuses on developing anti-cancer therapeutics for patients with unmet medical needs in Denmark and the United States. The company develops drugs for the personalized treatment of cancer using drug-specific companion diagnostics generated by its proprietary drug response predictor (DRP) technology. Its lead drug candidate is stenoparib, a dual inhibitor of poly-ADP-ribose polymerase (PARP1/2), which is in a Phase 2 clinical trial for patients with advanced ...